AI Analysis AI Analysis of AMPH
Powered by GPT-4o
New!
Stock Analysis PRO
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Amphastar Pharmaceuticals stock upgraded to Hold/Accumulate
(Updated on Jun 18, 2025)

Hold candidate since Jun 18, 2025

The Amphastar Pharmaceuticals stock price fell by -1.05% on the last day (Wednesday, 18th Jun 2025) from $25.61 to $25.34. During the last trading day the stock fluctuated 2.16% from a day low at $25.26 to a day high of $25.81. The price has been going up and down for this period, and there has been a -2.01% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -64 thousand shares and in total, 328 thousand shares were bought and sold for approximately $8.30 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.85% during the next 3 months and, with a 90% probability hold a price between $20.58 and $25.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

AMPH Signals & Forecast

The Amphastar Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $26.02. On a fall, the stock will find some support from the long-term average at approximately $25.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 10, 2025, and so far it has fallen -5.87%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Amphastar Pharmaceuticals stock

Amphastar Pharmaceuticals finds support from accumulated volume at $25.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.545 between high and low, or 2.16%. For the last week, the stock has had daily average volatility of 2.13%.

Our recommended stop-loss: $23.89 (-5.70%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (AMPH) For The Upcoming Trading Day Of Friday 20th

For the upcoming trading day on Friday, 20th we expect Amphastar Pharmaceuticals to open at $25.47, and during the day (based on 14 day Average True Range), to move between $24.59 and $26.09, which gives a possible trading interval of +/-$0.752 (+/-2.97%) up or down from last closing price. If Amphastar Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.94% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $25.23 (0.43%) than the resistance at $27.80 (9.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Amphastar Pharmaceuticals stock A Buy?

Amphastar Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.552 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 20, 2025 - $25.47 ( 0.506%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*

AMPH Performance

Trading levels for AMPH

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 26.01 2.66%
R2 25.81 1.84%
R1 25.68 1.33%
Price 25.34
S1 25.26 -0.315%
S2 25.13 -0.82%
S3 24.92 -1.64%

Accumulated Volume Support & Resistance Levels

Level Price
R3 28.39 12.04%
R2 28.29 11.64%
R1 27.80 9.71%
Price 25.34
S1 25.23 -0.434%
S2 25.00 -1.34%
S3 23.50 -7.26%

AMPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 07, 2010 Jun 11, 2010 Jun 30, 2010 $0.300 0%
2 Jun 05, 2009 Jun 11, 2009 Jun 30, 2009 $0.300 0%

FAQ

What is the symbol for Amphastar Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Amphastar Pharmaceuticals is AMPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amphastar Pharmaceuticals Stock.

What's the current price of Amphastar Pharmaceuticals Stock?
As of the end of day on the Jun 18, 2025, the price of an Amphastar Pharmaceuticals (AMPH) share was $25.34.

What is the 52-week high and low for Amphastar Pharmaceuticals Stock?
The 52-week high for Amphastar Pharmaceuticals Stock is $53.96 and the 52-week low is $22.66.

What is the market capitalization of Amphastar Pharmaceuticals Stock?
As of the Jun 18, 2025, the market capitalization of Amphastar Pharmaceuticals is 1.195B.

When is the next earnings date for Amphastar Pharmaceuticals?
The upcoming earnings date for Amphastar Pharmaceuticals is Aug 06, 2025.
Click to get the best stock tips daily for free!
ABOUT AMPHASTAR PHARMACEUTICALS
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Eno...
GOLDEN STAR
Ticker Change Signal Date
CACC
$487.05
2.63% Jun 04
G
GTM
$9.57
2.09% Jun 02
TAC
$8.90
26.97% May 12
UAA
$5.84
8.39% May 09
HBM
$7.41
33.33% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE